Pluri (PLUR) Shares Outstanding (Diluted Average) (2021 - 2025)

Pluri (PLUR) reported Shares Outstanding (Diluted Average) of $9.3 million for Q4 2025, up 66.77% year-over-year from $5.6 million in Q4 2024, and up 2.94% quarter-over-quarter from $9.0 million in Q3 2025.

Pluri (PLUR) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends

Pluri (PLUR) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $9.3 million in Q4 2025.

  • Shares Outstanding (Diluted Average) for Q4 2025 came in at $9.3 million, up 66.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.3 million (up 66.77% YoY), and the FY2025 annual result was $6.3 million, up 20.93% from the prior year.
  • Shares Outstanding (Diluted Average) advanced to $9.3 million in Q4 2025 per PLUR's latest filing, from $9.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $32.9 million in Q4 2022 and troughed at $4.4 million in Q1 2023.
  • A 5-year average of $14.8 million and a median of $6.5 million in 2025 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) plunged 86.35% in 2023, then jumped 66.77% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $32.1 million in 2021, then increased by 2.53% to $32.9 million in 2022, then sank by 84.25% to $5.2 million in 2023, then advanced by 7.23% to $5.6 million in 2024, then jumped by 66.77% to $9.3 million in 2025.
  • Business Quant data shows PLUR's Shares Outstanding (Diluted Average) at $9.3 million in Q4 2025, $9.0 million in Q3 2025, and $6.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 256.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - 92.44 Mn
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 9.26 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 9.26 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 6.34 Mn
Mar 31, 2025 6.56 Mn
Dec 31, 2024 5.55 Mn
Sep 30, 2024 5.46 Mn
Jun 30, 2024 5.24 Mn
Mar 31, 2024 5.22 Mn
Dec 31, 2023 5.18 Mn
Sep 30, 2023 5.17 Mn
Jun 30, 2023 4.58 Mn
Mar 31, 2023 4.40 Mn
Dec 31, 2022 32.88 Mn
Sep 30, 2022 32.56 Mn
Jun 30, 2022 32.19 Mn
Mar 31, 2022 32.26 Mn
Dec 31, 2021 32.07 Mn
Sep 30, 2021 32.00 Mn